Document and Entity Information
Document and Entity Information | Dec. 31, 2023 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Dec. 31, 2023 |
Entity Registrant Name | Omega Therapeutics, Inc. |
Entity Central Index Key | 0001850838 |
Entity Emerging Growth Company | true |
Securities Act File Number | 001-40657 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 81-3247585 |
Entity Address, Address Line One | 140 First Street |
Entity Address, Address Line Two | Suite 501 |
Entity Address, City or Town | Cambridge |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02141 |
City Area Code | 617 |
Local Phone Number | 949-4360 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Ex Transition Period | false |
Title of 12(b) Security | Common Stock, $0.001 par value per share |
Trading Symbol | OMGA |
Security Exchange Name | NASDAQ |